Additionally, STARD10 is linked to resilience against Paratuberculosis [70], STX2 against Escherichia coli [71], CCR9 shows potential for treating inflammatory bowel disease [72], and BANK1 regulates innate immune signaling in B cells [73]. Here, STX2 is linked to inflammatory bowel disease.